BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 7038650)

  • 1. [Antineoplastic effect of L-asparaginase].
    Opolski A
    Postepy Hig Med Dosw; 1981; 35(2):177-87. PubMed ID: 7038650
    [No Abstract]   [Full Text] [Related]  

  • 2. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
    Schwartz SA; Morgenstern B; Capizzi RL
    Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antineoplastic activity of L-asparaginase].
    Grgić Z
    Lijec Vjesn; 1969 Jul; 91(7):783-6. PubMed ID: 4910066
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immobilized asparaginase and its use in medicine].
    Kozlov EA; Petriĭ OP
    Vopr Med Khim; 1978; 24(6):723-33. PubMed ID: 32657
    [No Abstract]   [Full Text] [Related]  

  • 5. Solcoseryl effect on the cytostatic and antineoplastic activity of certain cytostatic agents.
    Danysz A; Polubiec A; Wronowski T; Jórasz I; Płomiński P; Jastrzebski Z; Cieśla J
    Acta Pol Pharm; 1987; 44(2):230-6. PubMed ID: 3434317
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy studies with L-asparaginase (NSC-109229) and other antitumor agents.
    Jacobs SP; Wodinsky I; Kensler CJ; Venditti JM
    Cancer Chemother Rep; 1970 Oct; 54(5):329-35. PubMed ID: 5514622
    [No Abstract]   [Full Text] [Related]  

  • 7. L-asparaginase--antileukemia agent.
    Bukhari SZ; Yaqub M
    J Pak Med Assoc; 1977 Jan; 27(1):262-4. PubMed ID: 19639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effective complexes of the antileukemic enzyme L-asparaginase with dextran sulfate].
    Karsakevich AS; Dauvarte AZh; Zvirgzda IK; Lebedeva LV; Vina IA
    Vopr Med Khim; 1986; 32(4):47-51. PubMed ID: 2429444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy].
    Nervi C; Casale C; Cortese M
    Policlinico Prat; 1969 Mar; 76(10):297-304. PubMed ID: 5252042
    [No Abstract]   [Full Text] [Related]  

  • 10. Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.
    Capizzi RL
    Cancer Treat Rep; 1981; 65 Suppl 4():115-21. PubMed ID: 7049375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Asparaginase, leukemia and cancer].
    Levy D; Boiron M
    Bull Cancer; 1969; 56(4):365-74. PubMed ID: 4928248
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
    Charles LM; Bono VH
    Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical modification of L-asparaginase with comb-shaped copolymer of poly(ethylene glycol) derivative and maleic anhydride.
    Saito T; Ueno T; Sekine T; Kodera Y; Hiroto M; Matsushima A; Nishimura H; Inada Y
    Leukemia; 1997 Apr; 11 Suppl 3():408-9. PubMed ID: 9209407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [L-asparaginase--first specific cytostatic].
    Marquardt H
    Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
    [No Abstract]   [Full Text] [Related]  

  • 15. L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia.
    Leventhal BG; Skeel RT; Yankee RA; Henderson ES
    Cancer Chemother Rep; 1970 Feb; 54(1):47-51. PubMed ID: 4945997
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental studies with L-asparaginase in mouse leukemias.
    Burchenal JH; Benvenisti D; Dollinger M
    Recent Results Cancer Res; 1970; 33():102-13. PubMed ID: 5292716
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental investigations on problems of the clinical use of L-asparaginase.
    Bierling R
    Recent Results Cancer Res; 1970; 33():114-24. PubMed ID: 4115400
    [No Abstract]   [Full Text] [Related]  

  • 18. Antileukemic effect of L-aspartyl-hydrazine.
    Stern P; Valjevac K; Balenović K
    Neoplasma; 1975; 22(1):69-71. PubMed ID: 1153038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases.
    Roberts J; Schmid FA; Old LJ; Stockert E
    Cancer Biochem Biophys; 1976 May; 1(4):175-8. PubMed ID: 788892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [First results of the treatment of acute leukemia with L-asparaginase].
    Marmont A; Damasio E; Bordo D; Fazio F; Gori E; Rossi F
    Haematologica; 1970; 55(9):593-6. PubMed ID: 4996527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.